FNLC vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

FNLC

59.2
AI Score
VS
CARE Wins

CARE

63.4
AI Score

Investment Advisor Scores

FNLC

Oct 21, 2026
59score
Recommendation
BUY

CARE

Oct 21, 2026
63score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric FNLC CARE Winner
Forward P/E 12.1951 13.6612 FNLC
PEG Ratio 0 0 Tie
Revenue Growth 12.9% 68.3% CARE
Earnings Growth 18.1% 253.9% CARE
Tradestie Score 59.2/100 63.4/100 CARE
Profit Margin 38.3% 44.9% CARE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY STRONG BUY CARE

Relative Price Performance (Last 90 Days)

FNLC 1M: +9.9% · 3M: +3.2% CARE 1M: -3.5% · 3M: -11.3%

Current Technical Phase

FNLC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 59

RSI (14): 58.9 · Price: $36.76

CARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 42

RSI (14): 41.7 · Price: $28.98

Fundamentals Snapshot

Metric FNLC CARE
Market Cap — —
Forward P/E 12.2 11.6
Trailing P/E 10.6 4.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.5% 0.6%
EPS 3.48 5.91
Dividend Yield 0.04% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.